PDK1 and familial pancreatic carcinoma: In one study, transiently silenced RelA increased Gemcitabine-induced cell killing (31), while in another study selective knockdown of RelA in combination with pyruvate dehydrogenase kinase (PDK1/2) enhanced radiation sensitivity of pancreatic cancer cells (32).